CN101716314B - Orally taken traditional Chinese medicine composite for treating bladder cancer - Google Patents

Orally taken traditional Chinese medicine composite for treating bladder cancer Download PDF

Info

Publication number
CN101716314B
CN101716314B CN2009102301036A CN200910230103A CN101716314B CN 101716314 B CN101716314 B CN 101716314B CN 2009102301036 A CN2009102301036 A CN 2009102301036A CN 200910230103 A CN200910230103 A CN 200910230103A CN 101716314 B CN101716314 B CN 101716314B
Authority
CN
China
Prior art keywords
grams
chinese medicine
bladder cancer
traditional chinese
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102301036A
Other languages
Chinese (zh)
Other versions
CN101716314A (en
Inventor
孟淑春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meng Shuchun
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009102301036A priority Critical patent/CN101716314B/en
Publication of CN101716314A publication Critical patent/CN101716314A/en
Application granted granted Critical
Publication of CN101716314B publication Critical patent/CN101716314B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an orally taken traditional Chinese medicine composite for treating bladder cancer, belonging to a traditional Chinese medicine preparation. The invention is characterized in that the composite is prepared from the following raw materials calculated by weight: 30g of tuckahoe, 25g of giant knotweed, 25g of oldenlandia diffusa, 25g of radix astragali, 25g of yam, 12g of dogwood, 10g of dodder, 10g of angelica, 10g of Cimicifuga foetida, 10g of radix pseudostellariae, 10g of phellodendron and 10g of Rhizoma Zedoariae. The composite has the action of tonifying qi, strengthening the body resistance, activating blood and dissolving stasis and clearing away heat evil and promoting diuresis, and can effectively control the diffusion and transfer of cancer cells, improve the body immunity without toxic or side effects.

Description

A kind of Chinese medicine composition of orally taken for curing bladder cancer
Technical field
The present invention relates to a kind of Chinese medicine composition of orally taken for curing bladder cancer, belong to the field of Chinese medicines.
Background technology
Tumor of bladder is a most common tumor in the urinary system.Higher in developed country or regional sickness rate, the sickness rate of external tumor of bladder is only second to carcinoma of prostate in the male urogenital organs tumor, occupy the 2nd; Then account for the first place at home, in recent years and the gesture of increase arranged.The bladder cancer pilosity was born between 40~60 years old, and the male is Duoed 3 times than the women.Primary disease mainly shows as painless hematuria, urinary tract infection symptom clinically, also can cause dilatation of ureter, and then forms hydronephrosis.
For the at present general doctor trained in Western medicine excision that adopts of this disease, adopt the chemicotherapy partner treatment then, but the phenomenon ubiquity of recurrence after operation, and the toxic and side effects of chemicotherapy often makes patient's internal organs be badly damaged, and immunologic mechanism sharply descends, and has to interrupt chemotherapy.
Summary of the invention
The objective of the invention is to overcome the deficiency that prior art exists, and a kind of Chinese medicine composition of orally taken for curing bladder cancer is provided, can more effective treatment bladder cancer.
The technical scheme that technical solution problem of the present invention is taked is: a kind of Chinese medicine composition of orally taken for curing bladder cancer, it is characterized in that, and make by the crude drug of following weight: Poria 30 grams, Rhizoma Polygoni Cuspidati 25 grams, Herba Hedyotidis Diffusae 25 grams, the Radix Astragali 25 grams, Rhizoma Dioscoreae 25 grams, Fructus Corni 12 grams, Semen Cuscutae 10 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Cimicifugae 10 grams, Radix Pseudostellariae 10 grams, Cortex Phellodendri 10 grams, Rhizoma Curcumae 10 grams.
Preparation and instructions of taking: with the Impurity removal of each crude drug, all medicines of receiving add 500 milliliters in water in marmite earlier, decoct half an hour, and potion on the one is taken at twice.Ten days is a course of treatment.
Pharmacological action:
Poria: sweet light, flat.Go into the heart, spleen, lung meridian.Eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, the edema distension, the phlegm retention cough with dyspnea, the sound of vomiting of vomitting is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
Rhizoma Polygoni Cuspidati: hardship, cold, return liver, lung, gallbladder meridian.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, dampness removing jaundice eliminating, relieving cough and asthma.This product bitter cold is fallen and is let out, and merit is arrogated to oneself removing damp-heat from the liver and the gallbladder, again can the promoting blood circulation to restore menstrual flow pain relieving.
Herba Hedyotidis Diffusae: heat clearing away, dampness removing, detoxifcation.Control dyspnea and cough due to lung-heat, tonsillitis.
The Radix Astragali: warm in nature, sweet in the mouth.Tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.Cure mainly weakness of the spleen and stomach, lack of appetite asthenia, deficiency of vital energy blood prostration, exterior deficiency spontaneous perspiration, night sweat.
Rhizoma Dioscoreae: sweet in the mouth, temperature.Go into lung, spleen, kidney channel.Spleen invigorating, tonifying the lung is reinforced the kidney, and benefit is smart.Control diarrhea due to hypofunction of the spleen, chronic dysentery, cough due to consumptive disease is quenched one's thirst, seminal emission, leukorrhagia, frequent micturition; The spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.Be used for that insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung are breathed with cough, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, deficiency-heat quench one's thirst.
Fructus Corni: invigorating the liver and kidney, Gu arresting seminal emission gas is collapse.Control soreness of waist and knee joint, dizzy, tinnitus, sexual impotence, seminal emission, frequent micturition, the deficiency of the liver cold and heat, incessant sweating due to debility, the heart shakes scattered pulse.
Semen Cuscutae: the tonifying liver pain, beneficial marrow makes eye bright.Control soreness of waist and knee joint, quench one's thirst, order is dark.
Radix Angelicae Sinensis: Gan Xin, temperature.Go into the heart, liver, spleen channel.Benefiting blood and regulating blood circulation, menstruction regulating and pain relieving is moisturized laxation.Control menoxenia, amenorrhea stomachache , mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; The dryness of the intestine dyschezia is heavy after the bloody dysentery; The carbuncle skin ulcer is stolen, injury from falling down.
Rhizoma Cimicifugae: yang invigorating, deliver rash, detoxifcation. control the seasonal epidemic pathogens epidemic disease, the headache cold and heat, laryngalgia, aphtha, macule are not saturating, carbuncle sore tumefacting virus.
Radix Pseudostellariae: tonifying the lung, strong board.Control the cough due to deficiency of the lung, insufficiency of the spleen lack of appetite, the cardiopalmus spontaneous perspiration, spirit is tired.
Cortex Phellodendri: hardship, cold.Go into kidney, urinary bladder channel.Heat clearing away, dampness, pathogenic fire purging removes steams, and skin ulcer is treated in detoxifcation.Be used for damp-heat dysentery, jaundice, leukorrhagia, pyretic stranguria, osteopyrexia and fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus.Pharmacological research shows that Cortex Phellodendri decocting liquid has inhibitory action external to gram-positive cocci and Gram-negative coccus, has resisting pathogenic microbes effect simultaneously, and can suppress the contractile response that caused by acetylcholine.
Rhizoma Curcumae: toil, temperature.Go into liver, spleen channel.The removing blood stasis circulation of qi promoting, the removing food stagnancy pain relieving.Be used for abdominal pain due to blood stasis, hepatosplenomegaly, trusted subordinate's distending pain, gather, women's blood stasis amenorrhea, the traumatic injury eating accumulation of having a pain.
After the present invention made up said medicine, its drug effect had synergism, and the Chinese medicine composition of this kind orally taken for curing bladder cancer can QI invigorating be set upright, blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis.Fast effective ingredient is delivered to bladder cancer, tumor of bladder focus, has effectively controlled the diffusion and the transfer of cancerous cell, put forward people's height immunity, have no side effect.
Clinical drug of the present invention is remarkably productive, and effective percentage reaches 92%, general tumor patient take medicine pain relief or improvement in five to 15 days, spirit heightens, take medicine one to three the course of treatment tumor obviously reduce or disappear, thereby reach the prolongation life that palliates the agonizing sufferings, improve quality of life and clinical cure.Thereby reach the purpose of treatment tumor of bladder disease.
Model case
Example 1, Liu so-and-so, man, 66 years old.Find to suffer from bladder cancer before 3 years,, checked before three months, find recurrence in certain hospital's row bladder cancer ablation, hematuria, dysuria is taken 3 courses of treatment of medicine of the present invention, transference cures such as hematuria and dysuria, repeatedly tumor is not seen in check, existing life is normal.
Example 2, grandson so-and-so, man, 61 years old.Did the bladder cancer ablation before 5 years.Last year, the mamillary neoplasm was found in check, was diagnosed as the adenocarcinoma of bladder postoperative recurrence.The patient takes treatment by Chinese herbs of the present invention three months, at the examination in hospital bladder neoplasm is not arranged.So far operate as normal is not seen recurrence.
Example 3, Zhao so-and-so, man, 58 years old.Go to hospital because of painless hematuria before the patient Yu Si, inspection is diagnosed as bladder cancer, not having other positions shifts, at hospital's row tumor of bladder resection operation, hematuria appears again in the patient before half a year, finds bladder tumor recurrence on inspection, the patient is through taking Drug therapy of the present invention after three courses of treatment, patient's hematuria transference cure, existing life is normal, does not see recurrence.
The specific embodiment
Embodiment one:
Prescription: Poria 30 grams, Rhizoma Polygoni Cuspidati 25 grams, Herba Hedyotidis Diffusae 25 grams, the Radix Astragali 25 grams, Rhizoma Dioscoreae 25 grams, Fructus Corni 12 grams, Semen Cuscutae 10 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Cimicifugae 10 grams, Radix Pseudostellariae 10 grams, Cortex Phellodendri 10 grams, Rhizoma Curcumae 10 grams.
Preparation and instructions of taking: with the Impurity removal of each crude drug, all medicines of receiving add 500 milliliters in water in marmite earlier, decoct half an hour, and potion on the one is taken at twice.Ten days is a course of treatment.

Claims (1)

1. the Chinese medicine composition of an orally taken for curing bladder cancer is characterized in that, is made by the crude drug of following weight: Poria 30 grams, Rhizoma Polygoni Cuspidati 25 grams, Herba Hedyotidis Diffusae 25 grams, the Radix Astragali 25 grams, Rhizoma Dioscoreae 25 grams, Fructus Corni 12 grams, Semen Cuscutae 10 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Cimicifugae 10 grams, Radix Pseudostellariae 10 grams, Cortex Phellodendri 10 grams, Rhizoma Curcumae 10 grams.
CN2009102301036A 2009-11-16 2009-11-16 Orally taken traditional Chinese medicine composite for treating bladder cancer Expired - Fee Related CN101716314B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102301036A CN101716314B (en) 2009-11-16 2009-11-16 Orally taken traditional Chinese medicine composite for treating bladder cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102301036A CN101716314B (en) 2009-11-16 2009-11-16 Orally taken traditional Chinese medicine composite for treating bladder cancer

Publications (2)

Publication Number Publication Date
CN101716314A CN101716314A (en) 2010-06-02
CN101716314B true CN101716314B (en) 2011-04-13

Family

ID=42431011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102301036A Expired - Fee Related CN101716314B (en) 2009-11-16 2009-11-16 Orally taken traditional Chinese medicine composite for treating bladder cancer

Country Status (1)

Country Link
CN (1) CN101716314B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103800842A (en) * 2014-03-10 2014-05-21 山东省千佛山医院 Traditional Chinese medicine composition for treating carcinoma of urinary bladder
CN103908581A (en) * 2014-04-21 2014-07-09 朱华亭 Drug for treating bladder cancer and preparation method thereof
CN106177368A (en) * 2016-10-10 2016-12-07 南宁多灵生物科技有限公司 A kind of Chinese medicine composition treating bladder cancer
CN111773291A (en) * 2019-04-04 2020-10-16 石小和 Composition for treating bladder cancer and preparation method thereof
CN111494524A (en) * 2020-05-20 2020-08-07 西安外事学院 Traditional Chinese medicine composition for treating bladder cancer and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何勇.膀胱癌中医及中西医结合诊疗模式初探.《国医论坛》.2006,第21卷(第6期),17. *

Also Published As

Publication number Publication date
CN101716314A (en) 2010-06-02

Similar Documents

Publication Publication Date Title
CN103656041A (en) Traditional Chinese medicine for treating cervical cancer
CN101716314B (en) Orally taken traditional Chinese medicine composite for treating bladder cancer
CN103110844A (en) Traditional Chinese medicine for treating acute tonsillitis
CN103230561B (en) Traditional Chinese medicine for treating frequent urination caused by deficiency of kidneys
CN101879288B (en) Chinese medicinal formula for treating hydronephrosis
CN101401918B (en) Chinese medicinal composition for treating fatty liver
CN102743567B (en) Traditional Chinese medicine for treating chronic prostatitis
CN104306944A (en) Oral medicine for treating varicosities
CN101693101A (en) Lanceolata radish seed decoction for treating chronic gastritis
CN104524109A (en) Medicine for treating kidney-yang deficiency involution form benign prostatic hyperplasia and preparing method
CN101926932A (en) Chinese medicinal preparation for treating chronic tonsillitis
CN103656329B (en) Medicinal liquor for treating chronic prostatitis
CN105250878A (en) Traditional Chinese medicine for treating sub-acute infective endocarditis
CN101966297A (en) Compound common macrocarpium fruit ginseng leaf decoction for treating vertigo
CN104288494A (en) Medicine for treating haemorrhoids
CN104740042A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN105687596A (en) Pelvic inflammatory disease treating medicine and preparation method thereof
CN103977170A (en) Oral medicine of traditional Chinese medicine for treating dampness-heat of liver channe
CN103536674A (en) Medicament composition capable of preventing melanin tumor
CN102688453A (en) Traditional Chinese medicine composite for treating breast cancer
CN103961586B (en) A kind of medicine treating vulvitis and preparation method
CN103127411A (en) Traditional Chinese medicine used for treating urinary tract infection disease
CN106266990A (en) A kind of can effective decoction medicine treating pelvic inflammatory disease and preparation method thereof
CN101249204B (en) Pulmonary tuberculosis treating Chinese medicine
CN105688176A (en) Traditional Chinese medicine hot-compress salt bag containing semen plantaginis and mangnolia officinalis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: MENG SHUCHUN

Free format text: FORMER OWNER: HE QINQIN

Effective date: 20110126

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Meng Shuchun

Inventor before: He Qinqin

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250014 NO. 53, JINGSHI ROAD, LIXIA DISTRICT, JI NAN CITY, SHANDONG PROVINCETO: 252000 LIAOCHENG THIRD PEOPLE S HOSPITAL, NO. 62, WEIYU ROAD, LIAOCHENG CITY, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: HE QINQIN TO: MENG SHUCHUN

TA01 Transfer of patent application right

Effective date of registration: 20110126

Address after: 252000 Shandong city of Liaocheng province Wei Yuk Road No. 62 Liaocheng Third People's Hospital

Applicant after: Meng Shuchun

Address before: 250014, No. ten, No. 53, Lixia District, Ji'nan City, Shandong Province

Applicant before: He Qinqin

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110413

Termination date: 20111116